Evidence map›Paper›PMID 25273290›Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2014

The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments.

Michael E Thase, David Kingdon, Douglas Turkington

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. CBT for severe mental disorder: a good product that is in danger of being over-extended.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  15. Off label CBT: a promising therapy or an adjunctive pluralistic therapeutic ingredient?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  16. Non-pharmacological and pharmacological treatments act on the same brain.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  17. Expand the applicability and acceptability of CBT approaches in mood disorders.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  18. The usefulness for indicated prevention of severe mental disorders should play a central part in the further development of CBT.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  19. CBT for psychosis: effectiveness, diversity, dissemination, politics, the future and technology.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
  20. Have the potential benefits of CBT for severe mental disorders been undersold?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Michael E ThasePerelman School of Medicine, University of Pennsylvania and Philadelphia Veterans Affairs Medical Center, 3535 Market St., Philadelphia, PA, 19104, USA.
David Kingdon
Douglas Turkington
University of Pennsylvania · USUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive behavior therapy (CBT), as exemplified by the model of psychotherapy developed and refined over the past 40 years by A.T. Beck and colleagues, is one of the treatments of first choice for ambulatory depressive and anxiety disorders. Over the past several decades, there have been vigorous efforts to adapt CBT for treatment of more severe mental disorders, including schizophrenia and the more chronic and/or treatment refractory mood disorders. These efforts have primarily studied CBT as an adjunctive therapy, i.e., in combination with pharmacotherapy. Given the several limitations of state-of-the-art pharmacotherapies for these severe mental disorders, demonstration of clinically meaningful additive effects for CBT would have important implications for improving public health. This paper reviews the key developments in this important area of therapeutics, providing a summary of the current state of the art and suggesting directions for future research.

Indexed as

adjunctive therapybipolar disorderCognitive behavior therapymajor depressive disordersschizophreniasevere mental disorderstreatment refractory depression

Identifiers

PMID25273290
PMCPMC4219058
OpenAlexW2053952802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.